Stocks › IMGN
IMGN
IMGN·USD
$31.23
+0.00 (+0.00%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
IMGN
IMGN
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
IMGNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of IMGN by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Thomas MacArthurHouse · R · NJ |
IMGNIMGN · Stock |
Purchase $1,001 - $15,000 |
Feb 8, 2017 | Jan 9, 2017 | Filing ↗ |
| Thomas MacArthurHouse · R · NJ |
IMGNIMGN · Stock |
Sale $1,001 - $15,000 |
Jan 7, 2017 | Dec 8, 2016 | Filing ↗ |
Whale Activity
Institutional 13F positions
No 13F positions in IMGN among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by IMGN insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
666 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| MITCHELL DEAN JDirector | Disposition to issuer | −103.0K | — | — | Feb 12, 2024 | Form 4 ↗ |
| Thackray Helen M.Director | Disposition to issuer | −3,074 | — | — | Feb 12, 2024 | Form 4 ↗ |
| Enyedy Mark JCHIEF EXECUTIVE OFFICER · Director | Disposition to issuer | −584.4K | — | — | Feb 12, 2024 | Form 4 ↗ |
| Wallace Richard JohnDirector | Disposition to issuer | −10.0K | — | — | Feb 12, 2024 | Form 4 ↗ |
| Coen Stacy AnnSVP & CHIEF BUSINESS OFFICER | Disposition to issuer | −73.3K | — | — | Feb 12, 2024 | Form 4 ↗ |
| Lentini ReneeVP & PRIN ACCTG OFFICER | Disposition to issuer | −14.7K | — | — | Feb 12, 2024 | Form 4 ↗ |
| Goldberg Mark AlanDirector | Disposition to issuer | −60.7K | — | — | Feb 12, 2024 | Form 4 ↗ |
| Arbuckle Stuart ADirector | Disposition to issuer | −5,381 | — | — | Feb 12, 2024 | Form 4 ↗ |
| Wingrove TheresaSVP OF REGULATORY AFFAIRS | Disposition to issuer | −21.0K | — | — | Feb 12, 2024 | Form 4 ↗ |
| Char DanielSVP & CHIEF LEGAL OFFICER | Disposition to issuer | −1,000 | — | — | Feb 12, 2024 | Form 4 ↗ |
| VASCONCELLES MICHAELEVP R&D & MEDICAL AFFAIRS | Disposition to issuer | −1,327 | — | — | Feb 12, 2024 | Form 4 ↗ |
| Coen Stacy AnnSVP & CHIEF BUSINESS OFFICER | Sale | −4,583 | $29.30 | $134K | Feb 5, 2024 | Form 4 ↗ |
| Wingrove TheresaSVP OF REGULATORY AFFAIRS | Sale | −12.0K | $29.30 | $352K | Feb 5, 2024 | Form 4 ↗ |
| Enyedy Mark JCHIEF EXECUTIVE OFFICER · Director | Sale | −20.1K | $29.28 | $589K | Feb 5, 2024 | Form 4 ↗ |
| Lentini ReneeVP & PRIN ACCTG OFFICER | Sale | −2,631 | $29.30 | $77K | Feb 5, 2024 | Form 4 ↗ |
| Coen Stacy AnnSVP & CHIEF BUSINESS OFFICER | Option exercise | +14.3K | $0.00 | $0 | Feb 2, 2024 | Form 4 ↗ |
| Wingrove TheresaSVP OF REGULATORY AFFAIRS | Option exercise | +29.6K | $0.00 | $0 | Feb 2, 2024 | Form 4 ↗ |
| Enyedy Mark JCHIEF EXECUTIVE OFFICER · Director | Option exercise | +51.2K | $0.00 | $0 | Feb 2, 2024 | Form 4 ↗ |
| Lentini ReneeVP & PRIN ACCTG OFFICER | Option exercise | +8,435 | $0.00 | $0 | Feb 2, 2024 | Form 4 ↗ |
| Wingrove TheresaSVP OF REGULATORY AFFAIRS | Sale | −187.7K | $29.64 | $5.6M | Jan 16, 2024 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding IMGN · SEC Form N-PORT
Funds report their holdings by CUSIP, and IMGN could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming IMGN as client
No lobbying filings found naming IMGN as the client.
Government Contracts
Federal awards to IMGN · USAspending
No federal contract awards found for IMGN.
U.S. Patents
Recent USPTO applications naming IMGN
No USPTO patent applications found for IMGN.
Annual Financials
From IMGN's 10-K filings · XBRL
No annual XBRL figures on record for IMGN. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in IMGN's price history.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About IMGN
From SEC EDGAR company records
No company profile on record.